The contamination or incorrect measurement of raw materials
used in the manufacture of pharmaceutical and healthcare
products poses a significant risk to patient safety. As a result,
regulatory requirements for raw material identification and QA/
QC manufacturing process have become increasingly stringent
and manufacturers are faced with the challenges of meeting these
requirements while simultaneously trying to improve productivity,
reduce costs and deliver innovative products to market. Suzanne
Schreyer, Sr. Applications Scientist at Rigaku Analytical Devices,
focuses on the Raman advantage for pharmaceutical manufacturing.
https://international-pharma.com/wp-content/uploads/2016/07/Man-1-Safe-Fast.pdf